HK Stock MarketDetailed Quotes

09966 ALPHAMAB-B

Watchlist
  • 3.380
  • -0.050-1.46%
Market Closed Jan 9 16:08 CST
3.25BMarket Cap-13.74P/E (TTM)

ALPHAMAB-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
27.18%173.56M
31.12%218.77M
154.75%136.47M
14.26%166.85M
--53.57M
--146.02M
----
----
----
----
Operating income
27.18%173.56M
31.12%218.77M
154.75%136.47M
14.26%166.85M
53.57M
146.02M
Cost of sales
7.11%-30.81M
-24.95%-55.24M
-123.79%-33.17M
-1,359.94%-44.21M
---14.82M
---3.03M
----
----
----
----
Operating expenses
7.11%-30.81M
-24.95%-55.24M
-123.79%-33.17M
-1,359.94%-44.21M
-14.82M
-3.03M
Gross profit
38.19%142.75M
33.35%163.54M
166.59%103.3M
-14.23%122.64M
38.75M
142.99M
Administrative expenses
-4.18%-34.64M
8.57%-79.34M
24.61%-33.24M
-12.32%-86.77M
-15.65%-44.1M
1.22%-77.25M
6.03%-38.13M
33.57%-78.21M
-64.55%-40.58M
-355.34%-117.74M
Research and development expenses
0.08%-194.53M
12.97%-407.52M
10.04%-194.68M
2.73%-468.24M
6.70%-216.4M
-45.32%-481.36M
-73.45%-231.95M
-98.76%-331.24M
-139.86%-133.72M
-154.01%-166.65M
Revaluation surplus
----
----
----
----
----
----
----
----
----
-1,963.20%-542.29M
-Changes in the fair value of other assets
----
----
----
----
----
----
----
----
----
-1,963.20%-542.29M
Special items of operating profit
-48.68%47.08M
3.36%124.91M
7.52%91.73M
637.64%120.86M
853.12%85.31M
352.41%16.38M
-88.53%8.95M
-164.61%-6.49M
13,713.79%78.01M
97.06%-2.45M
Operating profit
-19.57%-39.33M
36.31%-198.41M
75.89%-32.9M
21.97%-311.52M
47.75%-136.43M
4.02%-399.24M
-171.17%-261.13M
49.83%-415.94M
-64.47%-96.3M
-312.25%-829.13M
Financing cost
20.15%-5.56M
14.27%-12.18M
35.94%-6.97M
-7.77%-14.21M
-74.38%-10.88M
-11.47%-13.18M
8.33%-6.24M
-227.95%-11.83M
-2,795.32%-6.8M
-139.28%-3.61M
Earning before tax
-12.63%-44.9M
35.35%-210.59M
72.94%-39.86M
21.02%-325.72M
44.90%-147.31M
3.59%-412.42M
-159.32%-267.36M
48.63%-427.77M
-75.38%-103.1M
-310.96%-832.74M
After-tax profit from continuing operations
-12.63%-44.9M
35.35%-210.59M
72.94%-39.86M
21.02%-325.72M
44.90%-147.31M
3.59%-412.42M
-159.32%-267.36M
48.63%-427.77M
-75.38%-103.1M
-310.96%-832.74M
Earning after tax
-12.63%-44.9M
35.35%-210.59M
72.94%-39.86M
21.02%-325.72M
44.90%-147.31M
3.59%-412.42M
-159.32%-267.36M
48.63%-427.77M
-75.38%-103.1M
-310.96%-832.74M
Profit attributable to shareholders
-12.63%-44.9M
35.35%-210.59M
72.94%-39.86M
21.02%-325.72M
44.90%-147.31M
3.59%-412.42M
-159.32%-267.36M
48.63%-427.77M
-75.38%-103.1M
-455.74%-832.74M
Basic earnings per share
-25.00%-0.05
37.14%-0.22
75.00%-0.04
20.45%-0.35
44.83%-0.16
4.35%-0.44
-163.64%-0.29
70.32%-0.46
0.00%-0.11
-269.05%-1.55
Diluted earnings per share
-25.00%-0.05
37.14%-0.22
75.00%-0.04
20.45%-0.35
44.83%-0.16
4.35%-0.44
-163.64%-0.29
70.32%-0.46
0.00%-0.11
-269.05%-1.55
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024 (FY)Dec 31, 2023 (Q6)Jun 30, 2023 (FY)Dec 31, 2022 (Q6)Jun 30, 2022 (FY)Dec 31, 2021 (Q6)Jun 30, 2021 (FY)Dec 31, 2020 (Q6)Jun 30, 2020 (FY)Dec 31, 2019
Turnover 27.18%173.56M 31.12%218.77M 154.75%136.47M 14.26%166.85M --53.57M --146.02M ---- ---- ---- ----
Operating income 27.18%173.56M 31.12%218.77M 154.75%136.47M 14.26%166.85M 53.57M 146.02M
Cost of sales 7.11%-30.81M -24.95%-55.24M -123.79%-33.17M -1,359.94%-44.21M ---14.82M ---3.03M ---- ---- ---- ----
Operating expenses 7.11%-30.81M -24.95%-55.24M -123.79%-33.17M -1,359.94%-44.21M -14.82M -3.03M
Gross profit 38.19%142.75M 33.35%163.54M 166.59%103.3M -14.23%122.64M 38.75M 142.99M
Administrative expenses -4.18%-34.64M 8.57%-79.34M 24.61%-33.24M -12.32%-86.77M -15.65%-44.1M 1.22%-77.25M 6.03%-38.13M 33.57%-78.21M -64.55%-40.58M -355.34%-117.74M
Research and development expenses 0.08%-194.53M 12.97%-407.52M 10.04%-194.68M 2.73%-468.24M 6.70%-216.4M -45.32%-481.36M -73.45%-231.95M -98.76%-331.24M -139.86%-133.72M -154.01%-166.65M
Revaluation surplus ---- ---- ---- ---- ---- ---- ---- ---- ---- -1,963.20%-542.29M
-Changes in the fair value of other assets ---- ---- ---- ---- ---- ---- ---- ---- ---- -1,963.20%-542.29M
Special items of operating profit -48.68%47.08M 3.36%124.91M 7.52%91.73M 637.64%120.86M 853.12%85.31M 352.41%16.38M -88.53%8.95M -164.61%-6.49M 13,713.79%78.01M 97.06%-2.45M
Operating profit -19.57%-39.33M 36.31%-198.41M 75.89%-32.9M 21.97%-311.52M 47.75%-136.43M 4.02%-399.24M -171.17%-261.13M 49.83%-415.94M -64.47%-96.3M -312.25%-829.13M
Financing cost 20.15%-5.56M 14.27%-12.18M 35.94%-6.97M -7.77%-14.21M -74.38%-10.88M -11.47%-13.18M 8.33%-6.24M -227.95%-11.83M -2,795.32%-6.8M -139.28%-3.61M
Earning before tax -12.63%-44.9M 35.35%-210.59M 72.94%-39.86M 21.02%-325.72M 44.90%-147.31M 3.59%-412.42M -159.32%-267.36M 48.63%-427.77M -75.38%-103.1M -310.96%-832.74M
After-tax profit from continuing operations -12.63%-44.9M 35.35%-210.59M 72.94%-39.86M 21.02%-325.72M 44.90%-147.31M 3.59%-412.42M -159.32%-267.36M 48.63%-427.77M -75.38%-103.1M -310.96%-832.74M
Earning after tax -12.63%-44.9M 35.35%-210.59M 72.94%-39.86M 21.02%-325.72M 44.90%-147.31M 3.59%-412.42M -159.32%-267.36M 48.63%-427.77M -75.38%-103.1M -310.96%-832.74M
Profit attributable to shareholders -12.63%-44.9M 35.35%-210.59M 72.94%-39.86M 21.02%-325.72M 44.90%-147.31M 3.59%-412.42M -159.32%-267.36M 48.63%-427.77M -75.38%-103.1M -455.74%-832.74M
Basic earnings per share -25.00%-0.05 37.14%-0.22 75.00%-0.04 20.45%-0.35 44.83%-0.16 4.35%-0.44 -163.64%-0.29 70.32%-0.46 0.00%-0.11 -269.05%-1.55
Diluted earnings per share -25.00%-0.05 37.14%-0.22 75.00%-0.04 20.45%-0.35 44.83%-0.16 4.35%-0.44 -163.64%-0.29 70.32%-0.46 0.00%-0.11 -269.05%-1.55
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards IAS IAS IAS IAS IAS IAS IAS IAS IAS IAS
Audit Opinions -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion
Auditor -- Deloitte Guan Huang Chen Fang Certified Public Accountants -- Deloitte Guan Huang Chen Fang Certified Public Accountants -- Deloitte Guan Huang Chen Fang Certified Public Accountants -- Deloitte Guan Huang Chen Fang Certified Public Accountants -- Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday+0.69%